|
Market Cap (20-May) $8,702,824,448 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $15.15 |
P/E 59.52 |
EPS 0.15 |
TLX released this announcement to the ASX on 12 May 2021, 10:33. The announcement is not marked as price sensitive, and is 11 page(s) in length and 0.92MB in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 1.198% short sold according to ASIC data. It was ranked the 159th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| CEOs Address to AGM | 12 May 2021, 10:33 |
| Chairmans Address to AGM | 12 May 2021, 10:31 |
| Phase III Prostate Cancer Therapy Clinical Trial Commences | 10 May 2021, 8:21 |
| Executive Leadership Appointments and Establishment of APAC | 3 May 2021, 8:08 |
You must be logged in to post a reply.
Telix Pharmaceuticals 